Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMed

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Although it has been on the market for over a decade, confusion remains regarding the pharmacokinetics (PK) and optimal dosing of palivizumab, a humanized IgG1κ monoclonal antibody indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease. The objectives of this analysis were to characterize the population PK of palivizumab in adults and children using nonlinear mixed-effect modeling, quantify the effects of individual covariates on variabili

Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Acces

saved by

• Tammy Yu

related reading

• Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis - PMCncbi.nlm.nih.gov
• Projected growth of the adult congenital heart disease population in the United States to 2050: an integrative systems modeling approach - PubMedpubmed.ncbi.nlm.nih.gov
• Pharmacological Management of Pediatric Pustular Psoriasis - PubMedpubmed.ncbi.nlm.nih.gov
• Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
• Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness - PubMedpubmed.ncbi.nlm.nih.gov
• Acute Bronchitis - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMedpubmed.ncbi.nlm.nih.gov
• Receptor mediated uptake of peptides that bind the human transferrin receptor - PubMedpubmed.ncbi.nlm.nih.gov
• The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMedpubmed.ncbi.nlm.nih.gov
• Levofloxacin - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Intravenous Immunoglobulin (IVIG) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov